← Open Payments lookup

BRYNN CLYMER: Open Payments

NPI 1912281270 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,209 in 55 payments from 17 companies in 2025. Trend: 2023 $522 · 2024 $842 · 2025 $1,209

Food & beverage: $1,119Education: $90
CompanyPaymentsAmount
GlaxoSmithKline, LLC.16$349
Verona Pharma, Inc.9$153
GENZYME CORPORATION5$91
SANOFI-AVENTIS U.S. LLC1$90
Boehringer Ingelheim Pharmaceuticals, Inc.3$72
Takeda Pharmaceuticals U.S.A., Inc.3$62
ANI Pharmaceuticals, Inc.2$57
United Therapeutics Corporation2$57
Regeneron Healthcare Solutions, Inc.2$55
AstraZeneca Pharmaceuticals LP2$34

Products named: NUCALA, DUPIXENT, Ohtuvayre, OFEV, TRELEGY ELLIPTA, PURIFIED CORTROPHIN GEL, Tyvaso, GLASSIA.

Industry payments across TX — which companies pay providers there.